Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NXGL logo NXGL
Upturn stock ratingUpturn stock rating
NXGL logo

Nexgel Inc (NXGL)

Upturn stock ratingUpturn stock rating
$2.41
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/12/2025: NXGL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6

1 Year Target Price $6

Analysts Price Target For last 52 week
$6 Target price
52w Low $2.1
Current$2.41
52w High $5.1

Analysis of Past Performance

Type Stock
Historic Profit -32.56%
Avg. Invested days 28
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 19.44M USD
Price to earnings Ratio -
1Y Target Price 6
Price to earnings Ratio -
1Y Target Price 6
Volume (30-day avg) 1
Beta 0.58
52 Weeks Range 2.10 - 5.10
Updated Date 09/14/2025
52 Weeks Range 2.10 - 5.10
Updated Date 09/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.4

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -25.02%
Operating Margin (TTM) -22.05%

Management Effectiveness

Return on Assets (TTM) -19.51%
Return on Equity (TTM) -60.47%

Valuation

Trailing PE -
Forward PE 15.06
Enterprise Value 21372867
Price to Sales(TTM) 1.67
Enterprise Value 21372867
Price to Sales(TTM) 1.67
Enterprise Value to Revenue 1.83
Enterprise Value to EBITDA -0.85
Shares Outstanding 8067580
Shares Floating 6838323
Shares Outstanding 8067580
Shares Floating 6838323
Percent Insiders 15.54
Percent Institutions 8.94

ai summary icon Upturn AI SWOT

Nexgel Inc

stock logo

Company Overview

overview logo History and Background

Nexgel, Inc. (NXGL) is an innovative advanced wound care company developing, manufacturing and distributing high water content hydrogels, primarily for advanced wound care and consumer skin care applications. Founded to deliver next-generation hydrogel technology, Nexgel is focused on developing innovative, cost-effective hydrogels with broad applicability.

business area logo Core Business Areas

  • Advanced Wound Care: Nexgel develops and manufactures hydrogels used in dressings for chronic wounds, burns, and surgical incisions. These hydrogels promote healing by maintaining a moist environment and protecting the wound from infection.
  • Consumer Skin Care: Nexgel offers hydrogels for consumer skincare applications, such as moisturizing masks and cooling patches. These products leverage the hydrating and soothing properties of hydrogels.
  • Private Label & OEM: Nexgel manufactures hydrogels and converts them into finished goods for strategic partners on a private label and original equipment manufacturer (OEM) basis, in both the consumer and medical markets.

leadership logo Leadership and Structure

Curtis G. Cluff is the CEO and a director. Organizational details beyond this are limited in publicly available sources.

Top Products and Market Share

overview logo Key Offerings

  • Advanced Wound Care Dressings: Nexgel's hydrogel dressings are used in the treatment of chronic wounds, burns, and surgical incisions. Limited market share data is publicly available. Competitors include Smith & Nephew (SNN), Mu00f6lnlycke Health Care, and 3M (MMM).
  • Consumer Skin Care Masks: Nexgel's hydrogel masks are marketed for moisturizing and soothing the skin. Limited market share data is publicly available. Competitors include Johnson & Johnson (JNJ) and L'Oru00e9al (OR).
  • Private Label Hydrogel Products: Hydrogel products created for other companies. Exact numbers of customers/revenue not available.

Market Dynamics

industry overview logo Industry Overview

The advanced wound care market is driven by the increasing prevalence of chronic diseases like diabetes and obesity. The consumer skincare market is driven by aging populations and interest in skincare innovations. Hydrogel growth is due to its non-toxic properties, biocompatibility, and ability to create a moist wound healing environment.

Positioning

Nexgel positions itself as an innovator in hydrogel technology, offering cost-effective and versatile solutions for both medical and consumer applications. Their competitive advantage lies in their proprietary hydrogel formulation and manufacturing expertise. They aim to be a leader in hydrogel innovation.

Total Addressable Market (TAM)

The global advanced wound care market is estimated to reach tens of billions of dollars. The global cosmetic skin care market is estimated to reach hundreds of billions of dollars. Nexgel is positioned to capture a share of both of these markets with its innovative hydrogel technology, but the current market share is very small.

Upturn SWOT Analysis

Strengths

  • Innovative hydrogel technology
  • Cost-effective manufacturing
  • Versatile applications (wound care, skincare)
  • Private label and OEM opportunities

Weaknesses

  • Limited brand recognition
  • Small market share
  • Reliance on partners for distribution
  • Limited financial resources

Opportunities

  • Expanding into new wound care applications
  • Growing private label partnerships
  • Increasing consumer awareness of hydrogel benefits
  • Strategic acquisitions

Threats

  • Competition from established players
  • Regulatory hurdles
  • Fluctuations in raw material costs
  • Potential product liability claims

Competitors and Market Share

competitor logo Key Competitors

  • SNN
  • MMM
  • JNJ

Competitive Landscape

Nexgel faces stiff competition from established players with greater resources and brand recognition. Nexgel's advantages include its innovative hydrogel technology and cost-effective manufacturing, which allow it to compete on price and product performance. They are trying to improve on existing solutions by innovating on hydrogel technology.

Growth Trajectory and Initiatives

Historical Growth: Information unavailable without deeper data.

Future Projections: Future projections require analyst reviews.

Recent Initiatives: Nexgel's recent initiatives include expanding its private label partnerships and developing new hydrogel formulations for specific applications.

Summary

Nexgel is an innovative wound care company with promising hydrogel technology, but it faces challenges due to its small size and limited financial resources. The company's strengths lie in its cost-effective manufacturing and versatile applications, while its weaknesses include low brand recognition and reliance on partners. For Nexgel to become a significant player, it must improve its financial stability, brand awareness, and strategic position.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Website
  • SEC Filings
  • Industry Reports
  • Market Research Reports

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market data is based on available information and may not be entirely accurate. Consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Nexgel Inc

Exchange NASDAQ
Headquaters Langhorne, PA, United States
IPO Launch date 2021-12-22
CEO, President & Director Mr. Adam R. Levy
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 19
Full time employees 19

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.